Summary: The Fair Pricing Coalition and others are collecting signatures until this important Merck drug (the first integrase inhibitor) is approved and launched.
—————————————-
The Fair Pricing Coalition is asking Merck to price its new and very important integrase inhibitor at a level everyone can live with. The letter is seeking organization and individual signers until the official launch of the drug, when the price will be announced.
“A new HIV drug produced by Merck is about to be approved by the Food & Drug Administration in early October. While this is great news, especially for people who have developed resistance to existing therapies, the pricing of this treatment will have a major impact on the various publicly funded programs like Medicaid, Medicare, and the AIDS Drug Assistance Program, all of which are already straining at the breaking point.
“Please join the Fair Pricing Coalition by signing onto the following statement to Merck. …”
For the text of the letter and instructions for signing, visit
https://www.aidsnews.org/now/2007/09/pricing-of-new-hiv-drug-threatens.html
—————————————-
Also see our AIDS Treatment News Daily Alerts, updated every day at www.aidsnews.org/now
Return to home page: www.aidsnews.org
Free subscription to AIDS Treatment News announcements online: send a blank email to subscribe@aidsnews.org — and reply to the email request from Yahoo to confirm your subscription. You will receive about five emails or fewer per month and can leave the list at any time. Or just visit www.aidsnews.org to read the articles — no subscription or registration required. [Note: subscriptions to AIDS Treatment News Daily Alerts are handled separately at www.aidsnews.org/now]
Copyright 2007 by John S. James. We prefer that you link to www.aidsnews.org or a specific article — no permission required. Otherwise permission is granted for nonprofit use. Please check with us (aidsnews@aidsnews.org) before copying articles more than a year old.